Extracellular 5′-methylthioadenosine inhibits intracellular symmetric dimethylarginine protein methylation of FUSE-binding proteins-Reference-Cited by-同舟云学术

Extracellular 5′-methylthioadenosine inhibits intracellular symmetric dimethylarginine protein methylation of FUSE-binding proteins

Published:2022-09 Issue:9 Volume:298 Page:102367
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Tang Baiqing,Lee Hyung-Ok,Gupta Sapna,Wang Liqun,Kurimchak Alison M.,Duncan James S.,Kruger Warren D.

Funder

National Cancer Institute

Fox Chase Cancer Center

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference36 articles.

1. Methylthioadenosine nucleoside phosphorylase deficiency in methylthio-dependent cancer cells;Toohey;Biochem. Biophys. Res. Commun.,1978

2. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours;Cairns;Nat. Genet.,1995

3. High-resolution analysis of 9p loss in human cancer cells using single nucleotide polymorphism-based mapping arrays;Pei;Cancer Genet. Cytogenet.,2006

4. Abnormal regulation of methylthioadenosine and polyamine metabolism in methylthioadenosine phosphorylase-deficient human leukemic cell lines;Kamatani;Cancer Res.,1980

5. Down-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5'-deoxy-5'-methylthioadenosine (MTA);Kirovski;Am. J. Pathol.,2011

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combined inhibition of MTAP and MAT2a mimics synthetic lethality in tumor models via PRMT5 inhibition;Journal of Biological Chemistry;2024-01

2. Polyamines: their significance for maintaining health and contributing to diseases;Cell Communication and Signaling;2023-12-04

3. Exploring Therapeutic Avenues in Lung Cancer: The Epigenetic Perspective;Cancers;2023-11-13

4. Identification of a Protein Arginine Methyltransferase 7 (PRMT7)/Protein Arginine Methyltransferase 9 (PRMT9) Inhibitor;Journal of Medicinal Chemistry;2023-08-10